Download Citation
Article Source:
Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma
Perdomo-Pantoja A,
Mejía-Pérez SI,
Reynoso-Noverón N,
Gómez-Flores-Ramos L,
Soto-Reyes E,
et al.
(2018)
Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.
PLOS ONE 13(11): e0206590.
https://doi.org/10.1371/journal.pone.0206590